JoVE Logo
Faculty Resource Center

Sign In

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

DOI :

10.3791/59358-v

April 17th, 2019

April 17th, 2019

16,345 Views

1Department of Nuclear Medicine, Netherlands Cancer Institute

Well-differentiated neuroendocrine tumors overexpress somatostatin receptors which can be utilized for diagnostic imaging with the radiolabeled somatostatin analog 68Ga-DOTATATE. This protocol details the radiolabeling of 68Ga-DOTATATE, quality control, patient preparation, and subsequent PET/CT imaging. Radiation safety and time constrictions due to the short half-life of 68Ga are taken into account.

Tags

Production

-- Views

Related Videos

article

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

article

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

article

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

article

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

article

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

article

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

article

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

article

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

article

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

article

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved